ERBB2 and breast carcinoma: Nowadays, genomic studies have defined five main breast cancer subtypes (Luminal A, Luminal B, HER2-enriched, basal-like, claudin-low), each of them shows significant differences in incidence, survival and response to therapy [59, 60].